"Like many in this field, working in healthcare technology was a deliberate and very personal decision for me, and I’m deeply grateful to be part of Genomic Health’s mission. My passion and strength is in building high-growth businesses in healthcare technologies through innovative combinations of technologies and business models. Impacting the lives of cancer patients is immensely gratifying and comes with incredible responsibility, since progress and success is directly measured by the number of patient lives we can change. Genomic Health has shifted the paradigm in cancer disease management, benefiting hundreds of thousands of patients. The vision, boldness and tenacity that made Genomic Health what it is are in full force today, as we push forward on our journey to redefine cancer care by combining new diagnostic and information technologies, and continuing to lead our industry. This is not just a passion for our incredible team, but a responsibility. I am proud to be a part of it."
Over the last 25 years, Frederic Pla has built and launched global businesses in medical diagnostics and devices, life sciences, and healthcare information technology, consistently delivering high growth and profitability through a blend of product innovation, strategic acquisitions, and successful turnarounds. Frederic was Chief Business and Product Development Officer of Genomic Health from 2014 through 2017. He is currently Chief Operating Officer overseeing all research and development, lab, and other operational functions at Genomic Health. Before joining Genomic Health, Frederic was Vice President, Corporate Business Development, for Life Technologies, a $4 billion, 11,000-employee, San Diego-based global life sciences business, until its acquisition by Thermo Fisher in 2014. Frederic led many of the company’s internal and external growth initiatives, adding nearly $2.5 billion in yearly revenue through 30 acquisitions across areas such as diagnostics, food safety, animal health, bioinformatics, and life sciences tools. Frederic joined Life Technologies in 2005 as Vice President and General Manager of the Diagnostics Business, responsible for product development and manufacturing facilities in the U.S., UK, and China. Under Frederic’s leadership, this global business provided physicians with a complete set of tools to aid in solid organ and bone marrow transplant diagnostics, sold worldwide through a dedicated global sales force and distributor network. Prior to joining Life Technologies, Frederic held global managerial positions of increasing responsibility at GE Healthcare, including General Manager for the Cardiology IT and Enterprise IT businesses, where he contributed to the formation and growth of GE’s $2.4 billion Healthcare IT business, and Digital X-Ray Marketing, where he led the introduction of GE’s revolutionary digital X-Ray detector technology. Frederic started his career in R&D at the NASA Glenn Research Center in Cleveland, Ohio, and then at GE’s Global Research Center in Schenectady, N.Y. He is fluent in French, holds 23 U.S. patents, a Ph.D. in acoustics from the Pennsylvania State University, a Master’s degree from the University of Southampton, UK, and an engineering degree from the University of Technology of Compiegne, France.
Oncotype DX My Colon Cancer Coach